author_facet Lin, S.
He, L.
Shen, R.
Fang, F.
Pan, H.
Zhu, X.
Wang, M.
Zhou, Z.
Liu, Z.
Wang, X.
Fang, S.
Sun, X.
Wang, Y.
Chen, S.
Ding, J.
Lin, S.
He, L.
Shen, R.
Fang, F.
Pan, H.
Zhu, X.
Wang, M.
Zhou, Z.
Liu, Z.
Wang, X.
Fang, S.
Sun, X.
Wang, Y.
Chen, S.
Ding, J.
author Lin, S.
He, L.
Shen, R.
Fang, F.
Pan, H.
Zhu, X.
Wang, M.
Zhou, Z.
Liu, Z.
Wang, X.
Fang, S.
Sun, X.
Wang, Y.
Chen, S.
Ding, J.
spellingShingle Lin, S.
He, L.
Shen, R.
Fang, F.
Pan, H.
Zhu, X.
Wang, M.
Zhou, Z.
Liu, Z.
Wang, X.
Fang, S.
Sun, X.
Wang, Y.
Chen, S.
Ding, J.
European Journal of Neurology
Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
Neurology (clinical)
Neurology
author_sort lin, s.
spelling Lin, S. He, L. Shen, R. Fang, F. Pan, H. Zhu, X. Wang, M. Zhou, Z. Liu, Z. Wang, X. Fang, S. Sun, X. Wang, Y. Chen, S. Ding, J. 1351-5101 1468-1331 Wiley Neurology (clinical) Neurology http://dx.doi.org/10.1111/ene.14224 <jats:sec><jats:title>Background and purpose</jats:title><jats:p>Neuroinflammation is known to be involved in the pathogenesis of Parkinson's disease (PD). Abnormal activation of microglia plays a key role in this pathological process. CD200R1 is a membrane glycoprotein that is expressed primarily on myeloid cells including microglia and is involved in the maintenance of microglia in a stationary state. Our previous study reported that the regulation of CD200R1 expression is altered in PD patients. Such alteration will lead to neuroinflammation and is related to the pathogenesis of PD. The possible role of promoter polymorphisms for abnormal CD200R1 expression in PD was examined in this study.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>The UCSC database and dual‐luciferase assays were used to confirm the promoter region of CD200R1. The promoter of CD200R1 was sequenced in 457 PD patients and 520 matched healthy controls from the Chinese Han population. Dual‐luciferase assays were conducted to examine the promoter activity of CD200R1.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>It was confirmed that the promoter of CD200R1 is located in the region 876–146 bp upstream of the coding DNA sequence. The frequencies of rs144721913 (<jats:italic>P</jats:italic> = 0.001) and rs72952157 (<jats:italic>P</jats:italic> = 0.022) in the promoter were significantly different between the PD group and control group. rs144721913 increases the risk of PD by approximately 14‐fold and rs72952157 by 2.6‐fold. The dual‐luciferase assay indicated that the rs144721913 T allele and the rs72952157 G allele reduced the transcriptional activity of the CD200R1 promoter.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>For the first time the promoter region of CD200R1 has been defined and two potential risk polymorphisms (rs144721913 and rs72952157) in the region for PD in Chinese Han populations have been reported.</jats:p></jats:sec> Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease European Journal of Neurology
doi_str_mv 10.1111/ene.14224
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9lbmUuMTQyMjQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9lbmUuMTQyMjQ
institution DE-Gla1
DE-Zi4
DE-15
DE-Rs1
DE-Pl11
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
issn 1351-5101
1468-1331
issn_str_mv 1351-5101
1468-1331
language English
mega_collection Wiley (CrossRef)
match_str lin2020identificationofthecd200r1promoterandtheassociationofitspolymorphismswiththeriskofparkinsonsdisease
publishDateSort 2020
publisher Wiley
recordtype ai
record_format ai
series European Journal of Neurology
source_id 49
title Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_unstemmed Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_full Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_fullStr Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_full_unstemmed Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_short Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_sort identification of the cd200r1 promoter and the association of its polymorphisms with the risk of parkinson’s disease
topic Neurology (clinical)
Neurology
url http://dx.doi.org/10.1111/ene.14224
publishDate 2020
physical 1224-1230
description <jats:sec><jats:title>Background and purpose</jats:title><jats:p>Neuroinflammation is known to be involved in the pathogenesis of Parkinson's disease (PD). Abnormal activation of microglia plays a key role in this pathological process. CD200R1 is a membrane glycoprotein that is expressed primarily on myeloid cells including microglia and is involved in the maintenance of microglia in a stationary state. Our previous study reported that the regulation of CD200R1 expression is altered in PD patients. Such alteration will lead to neuroinflammation and is related to the pathogenesis of PD. The possible role of promoter polymorphisms for abnormal CD200R1 expression in PD was examined in this study.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>The UCSC database and dual‐luciferase assays were used to confirm the promoter region of CD200R1. The promoter of CD200R1 was sequenced in 457 PD patients and 520 matched healthy controls from the Chinese Han population. Dual‐luciferase assays were conducted to examine the promoter activity of CD200R1.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>It was confirmed that the promoter of CD200R1 is located in the region 876–146 bp upstream of the coding DNA sequence. The frequencies of rs144721913 (<jats:italic>P</jats:italic> = 0.001) and rs72952157 (<jats:italic>P</jats:italic> = 0.022) in the promoter were significantly different between the PD group and control group. rs144721913 increases the risk of PD by approximately 14‐fold and rs72952157 by 2.6‐fold. The dual‐luciferase assay indicated that the rs144721913 T allele and the rs72952157 G allele reduced the transcriptional activity of the CD200R1 promoter.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>For the first time the promoter region of CD200R1 has been defined and two potential risk polymorphisms (rs144721913 and rs72952157) in the region for PD in Chinese Han populations have been reported.</jats:p></jats:sec>
container_issue 7
container_start_page 1224
container_title European Journal of Neurology
container_volume 27
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792333140583251976
geogr_code not assigned
last_indexed 2024-03-01T14:08:00.821Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Identification+of+the+CD200R1+promoter+and+the+association+of+its+polymorphisms+with+the+risk+of+Parkinson%E2%80%99s+disease&rft.date=2020-07-01&genre=article&issn=1468-1331&volume=27&issue=7&spage=1224&epage=1230&pages=1224-1230&jtitle=European+Journal+of+Neurology&atitle=Identification+of+the+CD200R1+promoter+and+the+association+of+its+polymorphisms+with+the+risk+of+Parkinson%E2%80%99s+disease&aulast=Ding&aufirst=J.&rft_id=info%3Adoi%2F10.1111%2Fene.14224&rft.language%5B0%5D=eng
SOLR
_version_ 1792333140583251976
author Lin, S., He, L., Shen, R., Fang, F., Pan, H., Zhu, X., Wang, M., Zhou, Z., Liu, Z., Wang, X., Fang, S., Sun, X., Wang, Y., Chen, S., Ding, J.
author_facet Lin, S., He, L., Shen, R., Fang, F., Pan, H., Zhu, X., Wang, M., Zhou, Z., Liu, Z., Wang, X., Fang, S., Sun, X., Wang, Y., Chen, S., Ding, J., Lin, S., He, L., Shen, R., Fang, F., Pan, H., Zhu, X., Wang, M., Zhou, Z., Liu, Z., Wang, X., Fang, S., Sun, X., Wang, Y., Chen, S., Ding, J.
author_sort lin, s.
container_issue 7
container_start_page 1224
container_title European Journal of Neurology
container_volume 27
description <jats:sec><jats:title>Background and purpose</jats:title><jats:p>Neuroinflammation is known to be involved in the pathogenesis of Parkinson's disease (PD). Abnormal activation of microglia plays a key role in this pathological process. CD200R1 is a membrane glycoprotein that is expressed primarily on myeloid cells including microglia and is involved in the maintenance of microglia in a stationary state. Our previous study reported that the regulation of CD200R1 expression is altered in PD patients. Such alteration will lead to neuroinflammation and is related to the pathogenesis of PD. The possible role of promoter polymorphisms for abnormal CD200R1 expression in PD was examined in this study.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>The UCSC database and dual‐luciferase assays were used to confirm the promoter region of CD200R1. The promoter of CD200R1 was sequenced in 457 PD patients and 520 matched healthy controls from the Chinese Han population. Dual‐luciferase assays were conducted to examine the promoter activity of CD200R1.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>It was confirmed that the promoter of CD200R1 is located in the region 876–146 bp upstream of the coding DNA sequence. The frequencies of rs144721913 (<jats:italic>P</jats:italic> = 0.001) and rs72952157 (<jats:italic>P</jats:italic> = 0.022) in the promoter were significantly different between the PD group and control group. rs144721913 increases the risk of PD by approximately 14‐fold and rs72952157 by 2.6‐fold. The dual‐luciferase assay indicated that the rs144721913 T allele and the rs72952157 G allele reduced the transcriptional activity of the CD200R1 promoter.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>For the first time the promoter region of CD200R1 has been defined and two potential risk polymorphisms (rs144721913 and rs72952157) in the region for PD in Chinese Han populations have been reported.</jats:p></jats:sec>
doi_str_mv 10.1111/ene.14224
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9lbmUuMTQyMjQ
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
institution DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161
issn 1351-5101, 1468-1331
issn_str_mv 1351-5101, 1468-1331
language English
last_indexed 2024-03-01T14:08:00.821Z
match_str lin2020identificationofthecd200r1promoterandtheassociationofitspolymorphismswiththeriskofparkinsonsdisease
mega_collection Wiley (CrossRef)
physical 1224-1230
publishDate 2020
publishDateSort 2020
publisher Wiley
record_format ai
recordtype ai
series European Journal of Neurology
source_id 49
spelling Lin, S. He, L. Shen, R. Fang, F. Pan, H. Zhu, X. Wang, M. Zhou, Z. Liu, Z. Wang, X. Fang, S. Sun, X. Wang, Y. Chen, S. Ding, J. 1351-5101 1468-1331 Wiley Neurology (clinical) Neurology http://dx.doi.org/10.1111/ene.14224 <jats:sec><jats:title>Background and purpose</jats:title><jats:p>Neuroinflammation is known to be involved in the pathogenesis of Parkinson's disease (PD). Abnormal activation of microglia plays a key role in this pathological process. CD200R1 is a membrane glycoprotein that is expressed primarily on myeloid cells including microglia and is involved in the maintenance of microglia in a stationary state. Our previous study reported that the regulation of CD200R1 expression is altered in PD patients. Such alteration will lead to neuroinflammation and is related to the pathogenesis of PD. The possible role of promoter polymorphisms for abnormal CD200R1 expression in PD was examined in this study.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>The UCSC database and dual‐luciferase assays were used to confirm the promoter region of CD200R1. The promoter of CD200R1 was sequenced in 457 PD patients and 520 matched healthy controls from the Chinese Han population. Dual‐luciferase assays were conducted to examine the promoter activity of CD200R1.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>It was confirmed that the promoter of CD200R1 is located in the region 876–146 bp upstream of the coding DNA sequence. The frequencies of rs144721913 (<jats:italic>P</jats:italic> = 0.001) and rs72952157 (<jats:italic>P</jats:italic> = 0.022) in the promoter were significantly different between the PD group and control group. rs144721913 increases the risk of PD by approximately 14‐fold and rs72952157 by 2.6‐fold. The dual‐luciferase assay indicated that the rs144721913 T allele and the rs72952157 G allele reduced the transcriptional activity of the CD200R1 promoter.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>For the first time the promoter region of CD200R1 has been defined and two potential risk polymorphisms (rs144721913 and rs72952157) in the region for PD in Chinese Han populations have been reported.</jats:p></jats:sec> Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease European Journal of Neurology
spellingShingle Lin, S., He, L., Shen, R., Fang, F., Pan, H., Zhu, X., Wang, M., Zhou, Z., Liu, Z., Wang, X., Fang, S., Sun, X., Wang, Y., Chen, S., Ding, J., European Journal of Neurology, Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease, Neurology (clinical), Neurology
title Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_full Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_fullStr Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_full_unstemmed Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_short Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
title_sort identification of the cd200r1 promoter and the association of its polymorphisms with the risk of parkinson’s disease
title_unstemmed Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson’s disease
topic Neurology (clinical), Neurology
url http://dx.doi.org/10.1111/ene.14224